The PFA-SHAM trial and MANIFEST-US registry support the efficacy and safety of the increasingly used ablation modality.
EchoPrime was trained on more than 12 million videos; it’s now being tested clinically, with more data expected next year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback